| Literature DB >> 1588234 |
D Herbreteau1, M C Riche, O Enjolras, F Lemarchand, C Laurian, M D Brette, J J Merland.
Abstract
The use of Ethibloc must be contemplated as a first-intention treatment for venous malformations of the face. This sclerosing agent has transformed the functional, esthetic and psychological prognosis for these vascular malformations.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1588234
Source DB: PubMed Journal: J Mal Vasc ISSN: 0398-0499